Reaktion #4276
ord-0bc03ba9e5e2470fbc42b20b354ea151
Reaktionsgleichung
1-methyl-2-chloromethyl-5-(2'-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepine
m-trifluoromethyl aniline
potassium carbonate
sodium iodide
→
1-methyl-2-(3'-trifluoromethylphenyl)aminomethyl-5-(2'-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepine
Edukte
Reagenzien
Keine
Lösungsmittel
Reaktionsbedingungen
Detaillierte Bedingungen
See reaction.notes.procedure_details.
Aufarbeitung
- 1SonstigeAfter solvent-removal
- 2Sonstigepartitioning
- 3Sonstigeseparation
- 4Waschenwashing
- 5Sonstigedrying
- 6Einengenconcentrating
- 7Sonstigethe analytical product was obtained via chromatography on silica gel (ethyl acetate-hexane elution, 3:7 v/v)
Vorschrift
According to the method of Example 5, 1-methyl-2-chloromethyl-5-(2'-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepine (200 mg, 0.66 mmole) and m-trifluoromethyl aniline (319 mg, 1.97 mmole) were combined in 2 ml of dry N,N-dimethylformamide, and potassium carbonate (273 mg, 1.97 mmole) and sodium iodide (198 mg, 1.32 mmole) were added to this mixture (which was heated at 65° C. for 18 hours). After solvent-removal, partitioning, separation, washing, drying and concentrating, the analytical product was obtained via chromatography on silica gel (ethyl acetate-hexane elution, 3:7 v/v) and was shown to be 96% pure by HPLC.